Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stryker Blade Recall To Be Complete By September; OP-1 PMA Filed By FDA

This article was originally published in The Gray Sheet

Executive Summary

Stryker Instruments anticipates retrieving within 30 days certain lots of Heavy Duty blades recalled because of a "slight potential" for package failure that could affect the sterility of the devices.

You may also be interested in...

Stryker Management Trio Poised To Restore 20% Earnings Growth By 2000

Stryker's ability to successfully integrate Howmedica and return to historical earnings growth (20% annually the past two decades) by 2000 rests largely in the hands of three recently appointed Group Presidents - Ronald A. Elenbaas (Med-Surg), Edward "Ned" Lipes (Howmedica Osteonics U.S.) and Jack O'Mahony (Stryker International).


Completes acquisition of Pfizer's Howmedica orthopedic division for $1.65 bil. in cash, the firms report Dec. 4. The deal was first announced in August ("The Gray Sheet" Aug. 17, p. 3)

Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts